Brightech International

Sell-side

Exclusive Financial Advisor, December 2022

Brightech International
Acquired by Everest Clinical Research, a Portfolio Company of Arlington Capital Partners

Headquartered in Somerset, New Jersey, Brightech International (“Brightech” or “BTI”) is a global clinical research organization (“CRO”) with significant operations in both the United States and Taiwan. Brightech specializes in complex, value-added biostatistics, programming and clinical data management services. With management’s 160+ years of combined experience, Brightech’s solutions have assisted more than 100 leading pharmaceutical and biotechnology companies. Since inception, Brightech has completed more than 400 projects, serving clients in North America, Europe, and Asia.

More Like This

Jul 2023

Sold Majority Stake in hg medical to Astorg Mid-Cap

Exclusive Financial Advisor

View Details >
May 2023
Jounce Therapeutics Logo

Acquired by Concentra Biosciences

Exclusive Financial Advisor

View Details >
Mar 2023

Smile Source, a Portfolio Company of Brazos Private Equity Partners, has Partnered with Incline Equity Partners

Exclusive Financial Advisor

View Details >